Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Self-medication among pregnant women attending antenatal clinic at Makongoro health centre in Mwanza, Tanzania: a challenge to health systems.

Marwa KJ, Njalika A, Ruganuza D, Katabalo D, Kamugisha E.

BMC Pregnancy Childbirth. 2018 Jan 8;18(1):16. doi: 10.1186/s12884-017-1642-8.

2.

Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.

Kovacs SD, Mills BM, Stergachis A.

Malar J. 2017 Jul 11;16(1):282. doi: 10.1186/s12936-017-1921-x.

3.

First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.

Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, Kazienga A, Valéa I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, Ter Kuile F, Stergachis A.

PLoS Med. 2017 May 2;14(5):e1002290. doi: 10.1371/journal.pmed.1002290. eCollection 2017 May.

4.

Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.

Moore KA, Simpson JA, Paw MK, Pimanpanarak M, Wiladphaingern J, Rijken MJ, Jittamala P, White NJ, Fowkes FJI, Nosten F, McGready R.

Lancet Infect Dis. 2016 May;16(5):576-583. doi: 10.1016/S1473-3099(15)00547-2. Epub 2016 Feb 8.

5.

Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?

Cross R, Ling C, Day NP, McGready R, Paris DH.

Expert Opin Drug Saf. 2016;15(3):367-82. doi: 10.1517/14740338.2016.1133584. Epub 2016 Jan 25. Review.

6.

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.

Tinto H, Sevene E, Dellicour S, Calip GS, d'Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, Desai M, Ter Kuile F, Stergachis A.

Reprod Health. 2015 Dec 4;12:112. doi: 10.1186/s12978-015-0101-0.

7.

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya.

Dellicour S, Desai M, Aol G, Oneko M, Ouma P, Bigogo G, Burton DC, Breiman RF, Hamel MJ, Slutsker L, Feikin D, Kariuki S, Odhiambo F, Pandit J, Laserson KF, Calip G, Stergachis A, ter Kuile FO.

Malar J. 2015 Nov 18;14:461. doi: 10.1186/s12936-015-0950-6.

8.

Women's access and provider practices for the case management of malaria during pregnancy: a systematic review and meta-analysis.

Hill J, D'Mello-Guyett L, Hoyt J, van Eijk AM, ter Kuile FO, Webster J.

PLoS Med. 2014 Aug 5;11(8):e1001688. doi: 10.1371/journal.pmed.1001688. eCollection 2014 Aug. Review.

9.

Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings.

Mehta U, Clerk C, Allen E, Yore M, Sevene E, Singlovic J, Petzold M, Mangiaterra V, Elefant E, Sullivan FM, Holmes LB, Gomes M.

BMC Pregnancy Childbirth. 2012 Sep 3;12:89. doi: 10.1186/1471-2393-12-89.

10.

Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.

Rulisa S, Kaligirwa N, Agaba S, Karema C, Mens PF, de Vries PJ.

Malar J. 2012 Jul 6;11:225. doi: 10.1186/1475-2875-11-225.

11.

A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.

Manyando C, Kayentao K, D'Alessandro U, Okafor HU, Juma E, Hamed K.

Malar J. 2012 May 1;11:141. doi: 10.1186/1475-2875-11-141. Review.

12.

Patterns of anti-malarial drug treatment among pregnant women in Uganda.

Sangaré LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A.

Malar J. 2011 Jun 6;10:152. doi: 10.1186/1475-2875-10-152.

13.

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.

Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM.

Malar J. 2010 Sep 1;9:249. doi: 10.1186/1475-2875-9-249.

14.

Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Byakika-Kibwika P, Lamorde M, Mayanja-Kizza H, Merry C, Colebunders B, Van Geertruyden JP.

Ther Clin Risk Manag. 2010 Feb 2;6:11-20.

15.

Supplemental Content

Support Center